Bleeding after antiplatelet therapy for the treatment of acute coronary syndromes: a review of the evidence and evolving paradigms
出版年份 2019 全文链接
标题
Bleeding after antiplatelet therapy for the treatment of acute coronary syndromes: a review of the evidence and evolving paradigms
作者
关键词
-
出版物
Expert Opinion On Drug Safety
Volume 18, Issue 12, Pages 1171-1189
出版商
Informa UK Limited
发表日期
2019-10-18
DOI
10.1080/14740338.2019.1680637
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Development and Validation of a Novel Risk Score for In‐Hospital Major Bleeding in Acute Myocardial Infarction:—The SWEDEHEART Score
- (2019) Moa Simonsson et al. Journal of the American Heart Association
- Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers
- (2019) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
- (2019) Renato D. Lopes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting
- (2019) Francesco Costa et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reduced risk of gastrointestinal bleeding associated with proton pump inhibitor therapy in patients treated with dual antiplatelet therapy after myocardial infarction
- (2019) Thomas S G Sehested et al. EUROPEAN HEART JOURNAL
- De-escalation from ticagrelor to clopidogrel in acute coronary syndrome patients: a systematic review and meta-analysis
- (2019) Dominick J. Angiolillo et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention
- (2019) Philip Urban et al. CIRCULATION
- Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention
- (2019) Dirk Sibbing et al. JACC-Cardiovascular Interventions
- Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention
- (2019) Joo-Yong Hahn et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
- (2019) Hirotoshi Watanabe et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI
- (2019) Davide Capodanno et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
- (2019) Renato D. Lopes et al. JAMA Cardiology
- Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid–aspirin complex: results of a randomized, crossover, bioequivalence study
- (2019) Dominick J. Angiolillo et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Dual antithrombotic therapy for atrial fibrillation and PCI
- (2019) Davide Capodanno et al. LANCET
- Ticagrelor with or without Aspirin in High-Risk Patients after PCI
- (2019) Roxana Mehran et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI
- (2019) Daniel M.F. Claassens et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
- (2019) Stefanie Schüpke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tailoring P2Y 12 Inhibiting Therapy in Elderly Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
- (2019) Piera Capranzano et al. Journal of the American Heart Association
- Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score
- (2018) Sergio Raposeiras-Roubín et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes
- (2018) Giuseppe Gargiulo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial
- (2018) Joo-Yong Hahn et al. LANCET
- Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention
- (2018) Davide Capodanno et al. Nature Reviews Cardiology
- Evolution of Coronary Stent Technology and Implications for Duration of Dual Antiplatelet Therapy
- (2018) Jae Youn Moon et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Rationale and design of the EVOLVE Short DAPT Study to assess 3-month dual antiplatelet therapy in subjects at high risk for bleeding undergoing percutaneous coronary intervention
- (2018) Laura Mauri et al. AMERICAN HEART JOURNAL
- Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention
- (2018) Dominick J. Angiolillo et al. CIRCULATION
- Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
- (2018) Pascal Vranckx et al. LANCET
- Aspirin—still the GLOBAL LEADER in antiplatelet therapy
- (2018) Deepak L Bhatt LANCET
- Aspirin for primary prevention of cardiovascular disease
- (2018) Davide Capodanno et al. LANCET
- Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation with an abbreviated versus standard DAPT regimen (MASTER DAPT) study
- (2018) Enrico Frigoli et al. AMERICAN HEART JOURNAL
- Prospective observational cohort study of the association between antiplatelet therapy, bleeding and thrombosis in patients with coronary stents undergoing noncardiac surgery
- (2018) S.J. Howell et al. BRITISH JOURNAL OF ANAESTHESIA
- ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy
- (2018) Davide Capodanno et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Optimal duration of DAPT after second-generation drug-eluting stent in acute coronary syndrome
- (2018) Ji-Yong Jang et al. PLoS One
- Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial
- (2018) Elvin Kedhi et al. BMJ-British Medical Journal
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
- (2017) Marco Valgimigli et al. EUROPEAN HEART JOURNAL
- Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study
- (2017) Thomas Cuisset et al. EUROPEAN HEART JOURNAL
- Role for Thrombin Receptor Antagonism With Vorapaxar in Secondary Prevention of Atherothrombotic Events: From Bench to Bedside
- (2017) Jae Youn Moon et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Systematic Review and Meta-Analysis: Is Pre-Injury Antiplatelet Therapy Associated with Traumatic Intracranial Hemorrhage?
- (2017) Crispijn L. van den Brand et al. JOURNAL OF NEUROTRAUMA
- Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus
- (2017) Deepak L. Bhatt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dual antiplatelet therapy guided by platelet function testing
- (2017) Dominick J Angiolillo LANCET
- Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials
- (2017) Francesco Costa et al. LANCET
- Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
- (2017) E Magnus Ohman et al. LANCET
- Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial
- (2017) Dirk Sibbing et al. LANCET
- Antithrombotic therapy for patients with STEMI undergoing primary PCI
- (2017) Francesco Franchi et al. Nature Reviews Cardiology
- Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
- (2017) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- The quest for safer antithrombotic treatment regimens in patients with coronary artery disease: new strategies and paradigm shifts
- (2017) Jae Youn Moon et al. Expert Review of Hematology
- Incidence and outcome of switching of oral platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: the SCOPE registry
- (2017) Leonardo De Luca et al. EuroIntervention
- Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding
- (2017) Daniel Lindholm et al. Journal of the American Heart Association
- Role of genetic testing in patients undergoing percutaneous coronary intervention
- (2017) Jae Youn Moon et al. Expert Review of Clinical Pharmacology
- Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus
- (2016) Davide Capodanno et al. CIRCULATION
- Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: conceptual evolution based on emerging evidence
- (2016) Tullio Palmerini et al. EUROPEAN HEART JOURNAL
- A Safety Evaluation of Cangrelor in Patients Undergoing PCI
- (2016) Francesco Franchi et al. Expert Opinion On Drug Safety
- Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention
- (2016) Robert W. Yeh et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents
- (2016) Usman Baber et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes
- (2016) Pascal Vranckx et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
- (2016) C. Michael Gibson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blood Transfusion After Percutaneous Coronary Intervention and Risk of Subsequent Adverse Outcomes
- (2015) Chun Shing Kwok et al. JACC-Cardiovascular Interventions
- The Conundrum of Reducing Ischemic and Bleeding Events After PCI∗
- (2015) Sunil V. Rao JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trials
- (2015) Dominick J. Angiolillo et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Switching P2Y12-receptor inhibitors in patients with coronary artery disease
- (2015) Fabiana Rollini et al. Nature Reviews Cardiology
- Balancing the Risks and Benefits of Dual Platelet Inhibition
- (2015) John F. Keaney NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
- (2015) Marc P. Bonaca et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary
- (2014) Ezra A. Amsterdam et al. CIRCULATION
- Mechanisms of Plaque Formation and Rupture
- (2014) Jacob Fog Bentzon et al. CIRCULATION RESEARCH
- Prospective validation of the Bleeding Academic Research Consortium classification in the all-comer PRODIGY trial
- (2014) Pascal Vranckx et al. EUROPEAN HEART JOURNAL
- Rise and fall of glycoprotein IIb–IIIa inhibitors in ST-segment elevation myocardial infarction
- (2014) Carlo Di Mario HEART
- Novel antiplatelet agents in acute coronary syndrome
- (2014) Francesco Franchi et al. Nature Reviews Cardiology
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
- (2014) Laura Mauri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly Patients
- (2013) David Erlinge et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Discharge Aspirin Dose and Clinical Outcomes in Patients With Acute Coronary Syndromes Treated With Prasugrel Versus Clopidogrel
- (2013) Payal Kohli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antiplatelet therapy: new pharmacological agents and changing paradigms
- (2013) D. Capodanno et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data
- (2013) Philippe Gabriel Steg et al. LANCET
- Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study
- (2013) Roxana Mehran et al. LANCET
- Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events
- (2013) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes
- (2013) Gilles Montalescot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug Resistance and Pseudoresistance
- (2012) Tilo Grosser et al. CIRCULATION
- 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary
- (2012) Patrick T. O’Gara et al. CIRCULATION
- The Evolution of Antiplatelet Therapy in the Treatment of Acute Coronary Syndromes
- (2012) Dominick J. Angiolillo DRUGS
- Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery
- (2012) Dominick J. Angiolillo et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Reduction in Platelet Reactivity With Prasugrel 5 mg in Low-Body-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Body-Weight Patients
- (2012) David Erlinge et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials
- (2012) Dominick J. Angiolillo et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization
- (2012) Matthew T. Roe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vorapaxar in the Secondary Prevention of Atherothrombotic Events
- (2012) David A. Morrow et al. NEW ENGLAND JOURNAL OF MEDICINE
- In-Hospital Major Bleeding During ST-Elevation and Non–ST-Elevation Myocardial Infarction Care: Derivation and Validation of a Model from the ACTION Registry®-GWTG™
- (2011) Robin Mathews et al. AMERICAN JOURNAL OF CARDIOLOGY
- Long-Term Use of Aspirin and the Risk of Gastrointestinal Bleeding
- (2011) Edward S. Huang et al. AMERICAN JOURNAL OF MEDICINE
- Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial
- (2011) Kenneth W. Mahaffey et al. CIRCULATION
- Predictors of Bleeding and Time Dependence of Association of Bleeding With Mortality
- (2011) Willibald Hochholzer et al. CIRCULATION
- Standardized Bleeding Definitions for Cardiovascular Clinical Trials
- (2011) Roxana Mehran et al. CIRCULATION
- Upstream Use of Small-Molecule Glycoprotein IIb/IIIa Inhibitors in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes
- (2011) Pierluigi Tricoci et al.
- Gastrointestinal effects of aspirin
- (2011) Carlos Sostres et al. Nature Reviews Gastroenterology & Hepatology
- Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
- (2011) Pierluigi Tricoci et al. NEW ENGLAND JOURNAL OF MEDICINE
- Changes in glycoprotein IIb/IIIa inhibitor excess dosing with site-specific safety feedback in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) initiative
- (2010) Daniel W. Mudrick et al. AMERICAN HEART JOURNAL
- Low-Dose Aspirin-Induced Ulceration Is Attenuated by Aspirin–Phosphatidylcholine: A Randomized Clinical Trial
- (2010) Byron Cryer et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Basic Principles of Platelet Biology and Clinical Implications
- (2010) Dominick J. Angiolillo et al. CIRCULATION JOURNAL
- Antithrombotic Therapy in the Elderly
- (2010) Davide Capodanno et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes
- (2010) Roxana Mehran et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Case for Routine Genotyping in Dual-Antiplatelet Therapy
- (2010) Samir B. Damani et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation
- (2010) P. C. J. ARMSTRONG et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
- (2010) Shamir R Mehta et al. LANCET
- Clopidogrel with or without Omeprazole in Coronary Artery Disease
- (2010) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial
- (2009) Stefan James et al. AMERICAN HEART JOURNAL
- Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease
- (2009) Paul A. Gurbel et al. CIRCULATION
- Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction
- (2009) Sumeet Subherwal et al. CIRCULATION
- Platelet thrombin receptor antagonism and atherothrombosis
- (2009) D. J. Angiolillo et al. EUROPEAN HEART JOURNAL
- Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial
- (2009) R. Mehran et al. EUROPEAN HEART JOURNAL
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prasugrel: a novel platelet ADP P2Y12receptor antagonist. A review on its mechanism of action and clinical development
- (2008) Dominick J Angiolillo et al. EXPERT OPINION ON PHARMACOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started